Science Explorer Back to mapMap
Discussion
Company · Shijiazhuang · China

CSPC Pharmaceutical Group

cspc.com.hkROR OpenAlex
Research works
28
▲ 518% vs 2018-21
Citations
414
14.9 per fractional work
Top-10% rate
13.3%
all institutions 10.0%
Open access
31%
world 40%
International
7%
world 18%
CSPC Pharmaceutical Group

Not ranked overall: CSPC Pharmaceutical Group is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does CSPC Pharmaceutical Group work in?

In all years, 44% of research at CSPC Pharmaceutical Group is in Health Sciences, 38% in Life Sciences. Its largest fields are Medicine (43%), Biochemistry, Genetics and Molecular Biology (20%), Chemistry (9%). It does 1.9× the world's share of Life Sciences.

Health Sciences: 12 fractional works · 43.7% of its workMedicine: 12 fractional works · 43.3% of its workOncology: 3 fractional works · 10.6% of its workPulmonary and Respiratory Medicine: 1 fractional works · 5.3% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 3.9% of its workInfectious Diseases: 1 fractional works · 3.3% of its workSurgery: 1 fractional works · 3.1% of its workGenetics: 1 fractional works · 3.1% of its workImmunology and Allergy: 1 fractional works · 2.4% of its workPhysiology: 1 fractional works · 2.1% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 2.0% of its workPharmacology: 0 fractional works · 1.8% of its workEpidemiology: 0 fractional works · 1.4% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 1.4% of its workHematology: 0 fractional works · 0.7% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.6% of its workPathology and Forensic Medicine: 0 fractional works · 0.5% of its workNeurology: 0 fractional works · 0.5% of its workComplementary and alternative medicine: 0 fractional works · 0.3% of its workGastroenterology: 0 fractional works · 0.3% of its workNursing: 0 fractional works · 0.4% of its workNutrition and Dietetics: 0 fractional works · 0.4% of its workDentistry: 0 fractional works · 0.0% of its workLife Sciences: 11 fractional works · 38.3% of its workBiochemistry, Genetics and Molecular Biology: 6 fractional works · 20.4% of its workMolecular Biology: 3 fractional works · 10.8% of its workCancer Research: 1 fractional works · 3.1% of its workMolecular Medicine: 1 fractional works · 2.3% of its workGenetics: 0 fractional works · 1.8% of its workBiophysics: 0 fractional works · 1.6% of its workBiochemistry: 0 fractional works · 0.6% of its workCell Biology: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 2 fractional works · 7.4% of its workPharmaceutical Science: 2 fractional works · 6.8% of its workPharmacology: 0 fractional works · 0.6% of its workImmunology and Microbiology: 2 fractional works · 6.6% of its workApplied Microbiology and Biotechnology: 1 fractional works · 3.6% of its workImmunology: 1 fractional works · 2.4% of its workMicrobiology: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 1 fractional works · 3.1% of its workPlant Science: 0 fractional works · 1.2% of its workInsect Science: 0 fractional works · 1.1% of its workAnimal Science and Zoology: 0 fractional works · 0.8% of its workNeuroscience: 0 fractional works · 0.8% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysical Sciences: 5 fractional works · 17.9% of its workChemistry: 3 fractional works · 9.3% of its workOrganic Chemistry: 1 fractional works · 4.3% of its workAnalytical Chemistry: 1 fractional works · 2.2% of its workSpectroscopy: 0 fractional works · 1.6% of its workInorganic Chemistry: 0 fractional works · 1.2% of its workMaterials Science: 1 fractional works · 3.6% of its workMaterials Chemistry: 1 fractional works · 2.2% of its workBiomaterials: 0 fractional works · 0.8% of its workElectronic, Optical and Magnetic Materials: 0 fractional works · 0.6% of its workEngineering: 1 fractional works · 3.2% of its workBiomedical Engineering: 1 fractional works · 2.0% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 1.2% of its workEnvironmental Science: 0 fractional works · 1.4% of its workPollution: 0 fractional works · 0.6% of its workWater Science and Technology: 0 fractional works · 0.6% of its workEcology: 0 fractional works · 0.2% of its workMathematics: 0 fractional works · 0.4% of its workStatistics and Probability: 0 fractional works · 0.4% of its workALL ITS WORKCSPCPharmaceutical…28fractional works, all years
Life Sciences38%Physical Sciences18%Health Sciences44%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 13 fields, with their numbers
    1. Medicine1243.3%
    2. Nursing00.4%
    3. Dentistry00.0%
    1. Biochemistry, Genetics and Molecular Biology620.4%
    2. Pharmacology, Toxicology and Pharmaceutics27.4%
    3. Immunology and Microbiology26.6%
    4. Agricultural and Biological Sciences13.1%
    5. Neuroscience00.8%
    1. Chemistry39.3%
    2. Materials Science13.6%
    3. Engineering13.2%
    4. Environmental Science01.4%
    5. Mathematics00.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.35× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.86× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 4.24× its world share, 1 worksImmunology and Micro…Neuroscience: 1.01× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 7.01× its world share, 0 worksPharmacology, Toxico…Chemistry: 2.80× its world share, 1 worksChemistryEngineering: 0.05× its world share, 0 worksEngineeringEnvironmental Science: 0.58× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.24× its world share, 0 worksMaterials ScienceMathematics: 0.70× its world share, 0 worksMathematicsDentistry: 0.15× its world share, 0 worksDentistryMedicine: 3.06× its world share, 8 worksMedicineNursing: 1.68× its world share, 0 worksNursing1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 7.0×. Every wedge is a field page.

All 13 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics7.01×0 works
  2. Immunology and Microbiology4.24×1 works
  3. Biochemistry, Genetics and Molecular Biology3.86×3 works
  4. Medicine3.06×8 works
  5. Chemistry2.80×1 works
  6. Nursing1.68×0 works
  7. Neuroscience1.01×0 works
  8. Mathematics0.70×0 works
  9. Environmental Science0.58×0 works
  10. Agricultural and Biological Sciences0.35×0 works
  11. Materials Science0.24×0 works
  12. Dentistry0.15×0 works
  13. Engineering0.05×0 works

What are the most cited papers from CSPC Pharmaceutical Group?

The most cited paper from CSPC Pharmaceutical Group is "Preparation and Enhancement of Oral Bioavailability of Curcumin Using Microemulsions Vehicle" (Liandong Hu, Yanhong Jia, Feng Niu et al., 2012), with 117 citations. Next come "Highly water-soluble platinum(ii) complexes as GLUT substrates for targeted therapy: improved anticancer efficacy and transporter-mediated cytotoxic properties" (92) and "Development of glycyrrhetinic acid-modified stealth cationic liposomes for gene delivery" (92).

Most cited papers
#PaperReleasedCitations
1 Preparation and Enhancement of Oral Bioavailability of Curcumin Using Microemulsions Vehicle Liandong Hu, Yanhong Jia, Feng Niu et al. · Journal of Agricultural and Food Chemistry 15 May 2012 117
2 Highly water-soluble platinum(ii) complexes as GLUT substrates for targeted therapy: improved anticancer efficacy and transporter-mediated cytotoxic properties Pengxing Liu, Yanhui Lu, Xiangqian Gao et al. · Chemical Communications 2013 92
3 Development of glycyrrhetinic acid-modified stealth cationic liposomes for gene delivery Zhiyao He, Xi Emily Zheng, Xiao Wu et al. · International Journal of Pharmaceutics 27 Jul 2010 92
4 Enhancement of Oral Bioavailability of Curcumin by a Novel Solid Dispersion System Liandong Hu, Yanjing Shi, Jian Heng Li et al. · AAPS PharmSciTech Open access 24 Mar 2015 76
5 A preparation method for mRNA-LNPs with improved properties Cong Geng, Kefan Zhou, Yan Yan et al. · Journal of Controlled Release 16 Nov 2023 70
All 70 most cited papers, with filters and sorting

Which keywords describe research at CSPC Pharmaceutical Group?

By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Epidemiology, Breast Cancer, Nanoparticles, Drug Resistance, Cancer, Monoclonal Antibody and Cyclodextrins.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 16 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 16 words, with their numbers
  1. Epidemiology3▲ 2.7×14 topics
  2. Chemotherapy2▲ 12×10 topics
  3. Cancer2▲ 5.0×13 topics
  4. Nanoparticles2▲ 5.2×8 topics
  5. Breast Cancer2▲ 23×4 topics
  6. Inflammation2▲ 2.8×10 topics
  7. Drug Resistance2▲ 18×3 topics
  8. Monoclonal Antibody1▲ 70×2 topics
  9. Antioxidant1▲ 5.6×5 topics
  10. Cyclodextrins1▲ 178×1 topic
  11. Solid Dispersions1▲ 178×1 topic
  12. Antibiotic Resistance1▲ 8.9×1 topic
  13. Antimicrobial Stewardship1▲ 122×1 topic
  14. HER21▲ 121×1 topic
  15. Prognostic Factors1▲ 8.0×7 topics
  16. Trastuzumab1▲ 86×1 topic

Which research topics does CSPC Pharmaceutical Group publish most on?

By volume in 2022-now: HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, Chronic Lymphocytic Leukemia Research and Glioma Diagnosis and Treatment.

HER2/EGFR in Cancer Rese…1HER2/EGFR in Cancer Research: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksChronic Lymphocytic Leuk…0Chronic Lymphocytic Leukemia Research: 0 fractional worksGlioma Diagnosis and Tre…0Glioma Diagnosis and Treatment: 0 fractional worksRNA Interference and Gene Delivery: 0 fractional worksCell Adhesion Molecules Research: 0 fractional worksCancer Cells and Metasta…0Cancer Cells and Metastasis: 0 fractional worksHIV/AIDS drug development and treatment: 0 fractional worksCancer, Hypoxia, and Metabolism: 0 fractional worksAdvanced Breast Cancer T…0Advanced Breast Cancer Therapies: 0 fractional works
OncologyRadiology, Nuclear Medicine and ImagingGeneticsMolecular Biology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 HER2/EGFR in Cancer Research Oncology 1 works
  2. 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  3. 3 Chronic Lymphocytic Leukemia Research Genetics 0 works
  4. 4 Glioma Diagnosis and Treatment Genetics 0 works
  5. 5 RNA Interference and Gene Delivery Molecular Biology 0 works
  6. 6 Cell Adhesion Molecules Research Immunology and Allergy 0 works
  7. 7 Cancer Cells and Metastasis Oncology 0 works
  8. 8 HIV/AIDS drug development and treatment Infectious Diseases 0 works
  9. 9 Cancer, Hypoxia, and Metabolism Cancer Research 0 works
  10. 10 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available30.6%not open69.4%

World: 40% of research is openly available.

with international co-authors7.0%domestic only93.0%

World: 18% is written across borders.

How has CSPC Pharmaceutical Group's research output changed?

Output in 2022-2025 was 518% higher than in 2018-2021.

still counting2010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is CSPC Pharmaceutical Group as a percentage of every work published that year, 0.000047% in 2024.

still counting0.000050%0.00010%CSPC Pharmaceutical Group0.000038% in 202520102020

Fractional works of CSPC Pharmaceutical Group over all fractional works that year. How the balance of science has shifted.

Other research institutions in Shijiazhuang

All research institutions in Shijiazhuang

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about CSPC Pharmaceutical Group. Posts are plain text and can be reported.